-
MISSED APPOINTMENTS IN STROKE CARE: PATTERNS, IMPACT ON RECOVERY, COSTS, AND CLINICAL EFFICIENCY
Mar 18, 2026, 21:38 PM -
BEYOND COST AND QALYS: INTEGRATING THE APP SCORE TO IMPROVE COST-EFFECTIVENESS ANALYSIS OF DIGITAL HEALTH TECHNOLOGIES
Mar 18, 2026, 21:38 PM -
KEY OUTCOMES USED TO INFORM DECISION-MAKING IN ECONOMIC EVALUATIONS OF DIAGNOSTIC STRATEGIES IN HEPATITIS C AND D: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
IS SUICIDAL IDEATION RISK ASSOCIATED WITH PHARMACOTHERAPY IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)? A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING THE REPRESENTATIVENESS OF SURVEY-ELIGIBLE INDIVIDUALS IDENTIFIED FROM A LARGE US NATIONAL CLAIMS DATABASE
Mar 18, 2026, 21:38 PM -
UNCOVERING PATIENT AND CAREGIVER VOICES IN METASTATIC PROSTATE CANCER: A US SOCIAL MEDIA STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE PHARMACOECONOMIC ASSESSMENT OF CDK4/6 INHIBITORS IN A LARGE BRAZILIAN PRIVATE PAYER
Mar 18, 2026, 21:38 PM -
REAL-WORLD DEL(17P), TP53, AND IGHV BASELINE TESTING PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHIN A LARGE NETWORK OF US COMMUNITY ONCOLOGY PRACTICES
Mar 18, 2026, 21:38 PM -
AI-ASSISTED QUALITATIVE DATA EXTRACTION AND EVIDENCE MAPPING IN AN UMBRELLA REVIEW
Mar 18, 2026, 21:38 PM -
UNCERTAINTY PROBABILITY THRESHOLDS AND INSUFFICIENT ITERATIONS OF PROBABILISTIC SENSITIVITY ANALYSIS IN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
TWO-YEAR COST ANALYSIS OF RADICAL PROSTATECTOMY - INDEX PROCEDURES AND ADJUVANT THERAPIES
Mar 18, 2026, 21:38 PM -
RACING TO MARKET: WHAT HAPPENS AFTER FDA EXPEDITED APPROVAL IN ORPHAN DRUGS?
Mar 18, 2026, 21:38 PM -
ANTI-ISH VACCINATION: PATTERNS OF CHILDHOOD VACCINE UPTAKE IN THE FIRST 24 MONTHS IN CHILDREN VACCINATED OR NOT FOR MEASLES/MUMPS/RUBELLA
Mar 18, 2026, 21:38 PM -
ECONOMIC ANALYSES OF GENDER-AFFIRMING CARE: A LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL WORLD INSIGHTS INTO OBESITY CARE: UNDERSTANDING TREATMENT PATTERNS AND PAYER COSTS AT AN INTEGRATED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
REAL-WORLD CLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH CONCURRENT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) THERAPY AMONG PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) PRESCRIBED RESMETIROM
Mar 18, 2026, 21:38 PM -
COMPARABILITY OF OPEN AND CLOSED CLAIMS DATA FOR HEALTHCARE RESOURCE UTILIZATION ASSESSMENT IN ACUTE ISCHEMIC STROKE
Mar 18, 2026, 21:38 PM -
FACTORS EXPLAINING HPV VACCINE COMPLETION AMONG MEDICAID VACCINE INITIATORS IN KENTUCKY FROM 2010 TO 2022: AN APPLICATION OF GRADIENT BOOSTING
Mar 18, 2026, 21:38 PM -
AI/ML IN HTA EVIDENCE SYNTHESIS: WHERE DO WE STAND TODAY?
Mar 18, 2026, 21:38 PM -
THEMATIC LITERATURE REVIEW: CMS GENEROUS MODEL - DESIGN, EVIDENCE, AND SAVINGS OUTLOOK
Mar 18, 2026, 21:38 PM
